Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Curr Opin Oncol. 2017 Sep;29(5):366–374. doi: 10.1097/CCO.0000000000000389

Table 1.

Non-immunogenic immune-checkpoint blockade aptamers.

Target Chemistry Function Cancer Ref
PD-1 DNA Antagonist Colon cancer (49)
PD-L1 DNA Antagonist Colon /lung cancer (50)
TIM3 2´ fluoro-pyrimidine RNA Antagonist Colon cancer (51)
C5a L-aptamer Antagonist Lung cancer (52)